The tissues and biologics business will retain the RTI Surgical name, according to a Jan. 4 news release. Olivier Visa, CEO, will continue leading the Alachua, Fla.-based brand. It will focus on allograft and xenograft tissue-based implants.
The metals business, which focuses on implants and instruments for spine, orthopedic and cardiothoracic applications will be called Resolve Surgical Technologies. Megan Osorio, the current president of the metals business, will lead the company.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
